Identification of clinically relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c-Reference-Cited by-同舟云学术

Identification of clinically relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c

Published:2019-04-29 Issue: Volume: Page:
ISSN:1399-543X
Container-title:Pediatric Diabetes
language:en
Short-container-title:Pediatr Diabetes

Author:

Kahkoska Anna R.¹^ORCID,Adair Linda A.¹,Aiello Allison E.²,Burger Kyle S.¹,Buse John B.³,Crandell Jamie⁴,Maahs David M.⁵⁶,Nguyen Crystal T.⁷,Kosorok Michael R.⁷⁸,Mayer‐Davis Elizabeth J.¹³^ORCID

Affiliation:

1. Department of NutritionUniversity of North Carolina at Chapel Hill Chapel Hill North Carolina

2. Department of EpidemiologyUniversity of North Carolina at Chapel Hill Chapel Hill North Carolina

3. Department of MedicineUniversity of North Carolina at Chapel Hill Chapel Hill North Carolina

4. School of NursingUniversity of North Carolina at Chapel Hill Chapel Hill North Carolina

5. Department of Pediatrics, School of MedicineStanford University Stanford California

6. Stanford Diabetes Research CenterStanford University Stanford California

7. Department of BiostatisticsUniversity of North Carolina at Chapel Hill Chapel Hill North Carolina

8. Department of Statistics and Operations ResearchUniversity of North Carolina at Chapel Hill Chapel Hill North Carolina

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill

Leona M. and Harry B. Helmsley Charitable Trust

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pedi.12856

Reference40 articles.

1. Metrics beyond hemoglobin A1c in diabetes management: time in range, hypoglycemia, and other parameters;Wright LA‐C;Diabetes Technol Ther,2017

2. The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading;Beck RW;Diabetes Care,2017

3. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it?;Monnier L;J Diabetes Sci Technol,2008

4. HbA1c variability and the risk of microvascular complications in type 1 diabetes: data from the DCCT;Kilpatrick ES;Diabetes Care,2008

5. The relationship of hemoglobin A1C to time‐in‐range in patients with diabetes;Vigersky RA;Diabetes Technol Ther,2019

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterogeneity of glycaemic phenotypes in type 1 diabetes;Diabetologia;2024-05-23

2. Diabetes Technology and Therapy in the Pediatric Age Group;Diabetes Technology & Therapeutics;2024-03-01

3. Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data;Diabetes, Obesity and Metabolism;2024-02-26

4. Statistical Packages and Algorithms for the Analysis of Continuous Glucose Monitoring Data: A Systematic Review;Journal of Diabetes Science and Technology;2024-01-05

5. Use of wearables for monitoring cardiometabolic health: A systematic review;International Journal of Medical Informatics;2023-11